ADARx Pharmaceuticals Funding & Investors
ADARx Pharmaceuticals is a genetic medicine company focusing on the base editing of mRNA transcripts.
adarx.comTotal Amount Raised: $332,000,000
ADARx Pharmaceuticals Funding Rounds
Series B
$46,000,000
Series B Investors
Sr OneSirona CapitalLilly Asia VenturesAscenta CapitalOrbiMed AdvisorsSeries B
$75,000,000
Series B Investors
Sr OneSirona CapitalLilly Asia VenturesOrbiMed AdvisorsSeries C
$200,000,000
Series C Investors
Sr OneLilly Asia VenturesBain Capital Life SciencesAscenta CapitalMarshall WaceVenrock Healthcare Capital PartnersBlackRockHBM Healthcare InvestmentsRedmile GroupInvus GroupVivo CapitalCormorant Asset ManagementOrbiMed AdvisorsTCG CrossoverT. Rowe PriceCommodore CapitalSeries Unknown
$6,000,000
Series Unknown
$5,000,000
Funding info provided by Diffbot.